Changes in Central Arterial Pressure When Comparing Nifedipine/Labetalol for Routine Hypertension Control in Pregnancy

St. Louis University

Overview

To study central blood pressure changes caused by commonly used high blood pressure medications in pregnancy.

Central blood pressures in addition to pulse wave velocity will be attained prior to medication, and then every 30 minutes for 4 hours (total of 9 readings). Sphygmomanometer readings will be completed at the same time (total readings 9). These readings are all related to the study. Nursing will have the opportunity to to record the routine sphygmomanometer readings for their routine vitals if they chose to do so. Their participation will be complete after the 4 hour assessment is complete.

Study Type

OBSERVATIONAL

Conditions

Hypertension

Interventions

NifedipineOTHER

patients will be assigned to antihypertensive medications by their physicians in the course of their routine care

LabetalolOTHER

patients will be assigned to antihypertensive medications by their physicians in the course of their routine care

Eligibility

Sex: FEMALEMin age: 14 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Singleton pregnancy * Women with hypertensive disease in pregnancy who are currently being treated with nifedipine xl or labetalol Exclusion Criteria: * Multiple pregnancy * Currently on multiple anti-hypertension medications * Narcotic use * Irregular heart rhythms or arrhythmias * Peripheral arterial disease, leg artery disease * Reynaud's phenomena * Intense cold/hypothermia * If there is a wound at location of where central arterial cuff would be placed or tonometer for carotid assessment * Known sensitivity to labetalol or nifedipine * Severe tachycardia (\>120) * Greater than 1st degree heart block * Severe asthma * Congestive heart failure or heart disease * Lupus * Inability to adequately monitor BP * Currently receiving magnesium sulfate

Outcomes

Primary Outcomes

central blood pressure changes

Time frame: every 30 min for 4 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.